First Time Loading...
B

Brooklyn Immunotherapeutics Inc
NASDAQ:BTX

Watchlist Manager
Brooklyn Immunotherapeutics Inc
NASDAQ:BTX
Watchlist
Price: 0.2051 USD 0.05%
Updated: May 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Income Statement

5.8m
-71%
Revenue
Dec 31, 2020 5.8m
Dec 31, 2019 19.8m
Dec 31, 2018 23.3m
-5.4m
-345%
Operating Income
Dec 31, 2020 -5.4m
Dec 31, 2019 -1.2m
Dec 31, 2018 464k
-4.4m
-115%
Net Income
Dec 31, 2020 -4.4m
Dec 31, 2019 -2.1m
Dec 31, 2018 -275k

Earnings Waterfall
Brooklyn Immunotherapeutics Inc

Revenue
5.8m USD
Cost of Revenue
-2.9m USD
Gross Profit
2.9m USD
Operating Expenses
-8.3m USD
Operating Income
-5.4m USD
Other Expenses
968k USD
Net Income
-4.4m USD

Income Statement
Brooklyn Immunotherapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2018 Dec-2019 Dec-2020
Revenue
Revenue
23
N/A
20
-15%
6
-71%
Gross Profit
Cost of Revenue
(8)
(7)
(3)
Gross Profit
15
N/A
12
-19%
3
-77%
Operating Income
Operating Expenses
(15)
(14)
(8)
Selling, General & Administrative
(14)
(13)
(6)
Research & Development
0
(0)
(2)
Depreciation & Amortization
(0)
(0)
(0)
Operating Income
0
N/A
(1)
N/A
(5)
-345%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
Non-Reccuring Items
(0)
(1)
(1)
Total Other Income
(0)
(0)
2
Pre-Tax Income
(0)
N/A
(2)
-525%
(4)
-119%
Net Income
Tax Provision
0
(0)
0
Income from Continuing Operations
(0)
(2)
(4)
Net Income (Common)
(0)
N/A
(2)
-650%
(4)
-115%
EPS (Diluted)
-4.09
N/A
-28.7
-602%
-60.53
-111%

See Also

Summary
BTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BTX stock valuation using valuation multiples.
Wall Street Estimates
BTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.